Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CCL4 Antikörper (Biotin)

Der Kaninchen Polyklonal Anti-CCL4-Antikörper wurde für WB und EIA validiert. Er ist geeignet, CCL4 in Proben von Maus zu detektieren.
Produktnummer ABIN181625

Kurzübersicht für CCL4 Antikörper (Biotin) (ABIN181625)

Target

Alle CCL4 Antikörper anzeigen
CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

Reaktivität

  • 68
  • 46
  • 21
  • 11
  • 10
  • 10
  • 2
  • 2
  • 2
  • 1
Maus

Wirt

  • 113
  • 12
  • 3
  • 2
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 117
  • 15
Polyklonal

Konjugat

  • 74
  • 15
  • 13
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CCL4 Antikörper ist konjugiert mit Biotin

Applikation

  • 109
  • 53
  • 46
  • 40
  • 38
  • 13
  • 13
  • 13
  • 8
  • 8
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Spezifität

    This antibody detects Macrophage Inflammatory Protein-1 beta.

    Aufreinigung

    Affinity chromatography

    Immunogen

    Highly pure (> 98 %) recombinant murine MIP-1beta
  • Applikationshinweise

    ELISA: Direct: To detect mMIP-1β by direct ELISA (using 100 μL/well antibody solution) aconcentration of 0.25 - 1.0 μg/mL of this antibody is required. In conjunction withcompatible secondary reagents, it allows the detection of at least 0.2 - 0.4 ng/well ofrecombinant mMIP-1β. Sandwich: To detect mMIP-1β by sandwich ELISA (using 100 μL/well antibody solution) aconcentration of 0.25 - 1.0 μg/mL of this antibody is required. In conjunction withPolyclonal Anti-Murine MIP-1β as a capture antibody, it allows the detection of at least 0.2 -0.4 ng/well of recombinant mMIP-1β. Western Blot: To detect mMIP-1β by Western Blot analysis this antibody can be used at aconcentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagentsthe detection limit for recombinant mMIP-1β is 1.5 - 3.0 ng/lane, under either reducing or

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    Centrifuge vial prior to opening. Restore in sterile PBS containing 0.1 % BSA to a concentration of 0.1 - 1.0 mg/mL.

    Buffer

    PBS, pH 7.2

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store the lyophilized antibody at -20 °C. Following reconstitution it is stable for two weeks at 2 - 8 °C. Frozen aliquots are stable for 6 months when stored at -20 °C.

    Haltbarkeit

    6 months
  • Target

    CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

    Andere Bezeichnung

    MIP1 beta / CCL4

    Hintergrund

    MIP1 alpha and MIP1 beta were originally co-purified from medium conditioned by an LPS-stimulated murine macrophage cell line. Human MIP1 beta refers to the products of several independently cloned cDNAs, including Act2, PAT 744, hH400, G26, HIMAP, HC21, and MAD 5a. The predicted protein products of these cDNAs represent variants that are between 94 % - 98 % identical and these proteins are all approximately 75 % homologous to murine MIP1 beta. MIP1 beta also shares approximately 70 % amino acid identity with MIP1 alpha. MIP1 proteins are expressed primarily in T cells, B cells, and monocytes after antigen or mitogen stimulation. The MIP1 proteins have chemoattractant and adhesive effects on lymphocytes, with MIP1 alpha and MIP1 beta preferentially attracting CD8+ and CD4+ T cells, respectively. A signal transducing receptor designated the CC chemokine receptor 1 (CC CKR1) with seven transmembrane domains that binds MIP1 alpha, MIP1 beta, MCP1 and RANTES with varying affinities has been isolated.Synonyms: CCL-4, G-26 T-lymphocyte-secreted protein, HC21, LAG1, Lymphocyte activation gene 1 protein, MIP-1-beta, MIP1B, Macrophage inflammatory protein 1-beta, PAT744, Protein H400, SCYA4, SIS-gamma, Small-inducible cytokine A4, T-cell activation protein 2

    Gen-ID

    20303

    NCBI Accession

    NP_038680

    UniProt

    P14097
Sie sind hier:
Chat with us!